Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc.

NASDAQ:PRAX

Overview | Financials
Company Name Praxis Precision Medicines, Inc.
Symbol PRAX
Currency USD
Price 54.02
Market Cap 959,238,542
Dividend Yield 0%
52-week-range 13.005 - 67.21
Industry Biotechnology
Sector Healthcare
CEO Mr. Marcio Souza M.B.A.
Website https://www.praxismedicines.com

An error occurred while fetching data.

About Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and

Related Stocks

Adicet Bio, Inc. logo

Adicet Bio, Inc.

ACET

1.48 USD

Vaxart, Inc. logo

Vaxart, Inc.

VXRT

0.885 USD

Kinnate Biopharma Inc. logo

Kinnate Biopharma Inc.

KNTE

2.65 USD

Rallybio Corporation logo

Rallybio Corporation

RLYB

1.1 USD

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

14.2 USD

Alpha Tau Medical Ltd. logo

Alpha Tau Medical Ltd.

DRTS

2.275 USD

IRadimed Corporation logo

IRadimed Corporation

IRMD

44.89 USD

RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc.

RAPT

1.83 USD

Nuvalent, Inc. logo

Nuvalent, Inc.

NUVL

86.25 USD

Financials

Numbers are in millions USD

Numbers are in millions USD